Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin a single-domain antibody

From National Research Council Canada

Download
  1. (PDF, 1 MB)
DOIResolve DOI: https://doi.org/10.1038/s41598-018-20599-4
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleScientific Reports
ISSN2045-2322
Volume8
Issue1
Abstract
Publication date
PublisherNature Publishing Group
LanguageEnglish
Peer reviewedYes
NPARC number23002892
Export citationExport as RIS
Report a correctionReport a correction
Record identifier8467c362-ce77-4829-a8db-01b30a8a0bdf
Record created2018-03-21
Record modified2019-03-11
Date modified: